GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) » Definitions » Net Margin %

Tibet Rhodiola Pharmaceutical Holding Co (SHSE:600211) Net Margin % : 41.10% (As of Dec. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Tibet Rhodiola Pharmaceutical Holding Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Tibet Rhodiola Pharmaceutical Holding Co's Net Income for the three months ended in Dec. 2024 was ¥259 Mil. Tibet Rhodiola Pharmaceutical Holding Co's Revenue for the three months ended in Dec. 2024 was ¥631 Mil. Therefore, Tibet Rhodiola Pharmaceutical Holding Co's net margin for the quarter that ended in Dec. 2024 was 41.10%.

The historical rank and industry rank for Tibet Rhodiola Pharmaceutical Holding Co's Net Margin % or its related term are showing as below:

SHSE:600211' s Net Margin % Range Over the Past 10 Years
Min: 6.63   Med: 24.88   Max: 37.46
Current: 37.46


SHSE:600211's Net Margin % is ranked better than
97.03% of 975 companies
in the Drug Manufacturers industry
Industry Median: 4.6 vs SHSE:600211: 37.46

Tibet Rhodiola Pharmaceutical Holding Co Net Margin % Historical Data

The historical data trend for Tibet Rhodiola Pharmaceutical Holding Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tibet Rhodiola Pharmaceutical Holding Co Net Margin % Chart

Tibet Rhodiola Pharmaceutical Holding Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.45 9.77 14.48 25.55 37.46

Tibet Rhodiola Pharmaceutical Holding Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.10 44.43 34.07 30.09 41.10

Competitive Comparison of Tibet Rhodiola Pharmaceutical Holding Co's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Tibet Rhodiola Pharmaceutical Holding Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tibet Rhodiola Pharmaceutical Holding Co's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tibet Rhodiola Pharmaceutical Holding Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Tibet Rhodiola Pharmaceutical Holding Co's Net Margin % falls into.


;
;

Tibet Rhodiola Pharmaceutical Holding Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Tibet Rhodiola Pharmaceutical Holding Co's Net Margin for the fiscal year that ended in Dec. 2024 is calculated as

Net Margin=Net Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=1051.288/2806.713
=37.46 %

Tibet Rhodiola Pharmaceutical Holding Co's Net Margin for the quarter that ended in Dec. 2024 is calculated as

Net Margin=Net Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=259.421/631.27
=41.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tibet Rhodiola Pharmaceutical Holding Co  (SHSE:600211) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Tibet Rhodiola Pharmaceutical Holding Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Tibet Rhodiola Pharmaceutical Holding Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tibet Rhodiola Pharmaceutical Holding Co Business Description

Traded in Other Exchanges
N/A
Address
No. 93, Beijing Middle Road, Tibet Autonomous Region, Lhasa, CHN, 610023
Tibet Rhodiola Pharmaceutical Holding Co is a Chinese company producing biological products and traditional Tibetan medicines.
Executives
Wang Bao Ming senior management
Peng Hui Director
Cao Shu Zhen senior management
Si Qin Director
Ren Bei Chen Supervisors
Liu De Gong Supervisors
Gao Zi Li senior management
Zhou Ming De senior management
Chen Li Ye senior management
Lin Ben Director
Chen Da Bin Director

Tibet Rhodiola Pharmaceutical Holding Co Headlines

No Headlines